Medicine Archives - Hiarai.com

Communicating the Value of Approved Therapies

In a video interview with Pharma Commerce, Derrick Gastineau, head of marketing with Currax Pharmaceuticals, emphasizes the importance of pricing

A Deep Dive Into FDA’s Approval of First OTC Birth Control Pill

Image Credit: Adobe Stock Images/9DreamStudio.com In 2023, the FDA approved the first over-the-counter (OTC) birth control pill for use in

Oral Weight Loss Treatments Offer Patients and Clinicians New Options in Obesity Care

In a video interview with Pharma Commerce, Derrick Gastineau, head of marketing with Currax Pharmaceuticals, emphasizes the importance of pricing

New Phononic–Peltier Partnership Targets Safer, Smarter Cold Chain for Medicines

Image Credit: Adobe Stock Images/DragoDesigner.com Phononic, a company that specializes cooling technology, including for the pharma sector, has reached a

Ascensia to Transfer Eversense CGM Commercial Operations to Senseonics

Image Credit: Adobe Stock Images/Jordi.com Ascensia Diabetes Care—a part of PHC Group—has signed a memorandum of understanding (MOU) to transfer

What the President’s Drug Pricing Push Means for Pharma, Payers, and Patients

Ned Milenkovich, PharmD, JD The Most Favored Nation Mandate: What the President’s Drug Pricing Push Means for Pharma, Payers, and

Samsung Biologics Secures $1.3B US Manufacturing Deal Amidst Tariff Uncertainty

Image Credit: Adobe Stock Images/Wichayada.com According to FirstWord Pharma, Samsung Biologics, a contract development and manufacturing organization (CDMO) based in

DHL Supply Chain Acquires SDS Rx, Expanding Last-Mile Healthcare Logistics

Mark Kunar of DHL Supply Chain North America (left) and Drew Kronick of SDS Rx (right). Image Credit: DHL Supply

Consistent Cash-Pay Options Could Transform Access to Obesity Medications

In a video interview with Pharma Commerce, Derrick Gastineau, Head of Marketing with Currax Pharmaceuticals, emphasizes the importance of pricing

White House Eyes China Drug Restrictions, Pfizer-BioNTech Vaccine Data Strong, and Samsung Biologics Secures US Deal

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

Harnessing Tech to Build Resilient Hospital Supply Chains

Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In

Measles Outbreak Spurs Vaccine Mandate Debate, Trump Eyes DTC Ad Restrictions, and ICER Reviews GLP-1 Costs

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

ICER Releases Cost Analysis Report on Obesity Treatments Semaglutide, Tirzepatide

Image Credit: Adobe Stock Images/Enigma Topline Findings Significant Weight Loss Achieved: Zepbound delivers 17.8%–20.8% average weight loss, while injectable Wegovy

Novartis Expands Cardiovascular Pipeline, Flu Severity Drivers Identified in Seniors, and Fixing Medication Nonadherence

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

Hospitals Weigh ROI of RFID and RTLS for Smarter Medication Management

Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In

FDA Blocks Compounded GLP-1 Ingredients, RSV Vaccination Benefits Seniors, and Pharmacies Struggle With Pricing Program

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

Transforming Hospital Pharmacy Inventory Management

Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In

Gilead Expands R&D Hub, WHO Adds GLP-1s to Essential Medicines List, and High-Dose Flu Vaccine Shows Heart Benefits

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

Amgen Invests $600M in Innovation Hub, Novartis Collaborates With Argo, and Wegovy Tops Tirzepatide in Heart Outcomes

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

AI’s New Role in Pharma Strategy

Avinob Roy, Vice President & General Manager of Global Commercial Product Offerings at IQVIA, spoke with Pharmaceutical Commerce about how

Trump Appeals Tariff Ruling, Sanofi Shares Slide on Trial Miss, and COVID-19 Alters Pneumococcal Mortality

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

Gilead Breaks Ground on Technical Development Hub to Drive US Biopharma Innovation

Image Credit: Adobe Stock Images/SundryPhotography.com Gilead Sciences has unveiled its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC),

How Drug Shortages Could Disrupt Hospital Operations and Strain Patient Care

Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In

Trump Pushes Supreme Court to Save Tariffs After Appeals Court Ruling Limits Presidential Power

Image Credit: Adobe Stock Images/Philip.com Last night, the Trump administration requested that the US Supreme Court hear out an appeal

Overcoming Barriers to Full e-Prescribing Adoption

The Prescription Information Modernization Act of 2025 (PIMA) is being hailed as a significant development for the pharmaceutical industry because

Amgen to Invest $600M in New Science and Innovation Center at California HQ

Image Credit: Adobe Stock Images/MichaelVi.com Amgen will be financially committing upwards of $600 million into a new, state-of-the-art, science and innovation center at

Why Reducing Paper Inserts Is About Access as Much as Sustainability

The Prescription Information Modernization Act of 2025 (PIMA) is being hailed as a significant development for the pharmaceutical industry because

Modernizing Prescription Information

The Prescription Information Modernization Act of 2025 (PIMA) is being hailed as a significant development for the pharmaceutical industry because

Moving from Omnichannel to Optichannel Engagement Strategies: Your Questions Answered

Life science marketing is changing. Practices which worked for the blockbuster drug era are no longer appropriate for today’s environment

Pharma Supply Chain Faces Risks of Tariffs Driving Excess Inventory

In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a

Child Vaccines Show Adult Protection, Lilly Pauses Mounjaro Shipments, and FDA Rejects Lytenava Resubmission

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

ACOG Reaffirms COVID-19 Vaccine in Pregnancy, SGLT2 Real-World Safety Data, and EVERSANA–Waltz Tackle Drug Costs

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

Cold Chain Technologies Expands APAC Presence With New Hubs, Distributors, and Manufacturing Investment

Image Credit: Cold Chain Technologies Cold Chain Technologies (CCT), is solidifying its commitment to growing its Asia-Pacific (APAC) presence by

CDC Director Pushback, Persistent Drug Shortages, and FDA Clears First Generic GLP-1 for Weight Loss

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

Mitigating Pharmaceutical Supply Chain Challenges

Thani Jambulingam, PhD, professor of food, pharma, and healthcare business at Saint Joseph’s University’s Erivan K. Haub School of Business,

Pharmaceutical Commerce Presents The Most Favored Nation Mandate

Pharmaceutical Commerce presents The Most Favored Nation Mandate webinar! Earlier this year, Donald Trump issued an executive order stating that

Eli Lilly Pauses UK Mounjaro Shipments Ahead of 170% Price Hike

Image Credit: Adobe Stock Images/KKStock.com With an increase in price forthcoming, Eli Lilly has decided to temporarily pause UK shipments

Balancing Tariffs and Patient Access in Pharma Policy

In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a

The Great Pharma Reshoring

This video was created based on various Pharma Commerce articles: AbbVie Invests $195 Million to Expand Stateside API Manufacturing AstraZeneca

FDA Greenlights New COVID Vaccines, Sets Eligibility Limits

Credit: Tada Images | stock.adobe.com The FDA has authorized the use of updated COVID-19 vaccines for the upcoming fall season,

EVERSANA, Waltz Health Form Combined Platform to Tackle Drug Costs and Access Challenges

Image Credit: Adobe Stock Images/Stas_Malyarevsky.com EVERSANA, a global services provider to the life sciences sector, and Waltz Health, a digital

AI Fuels Surge in Counterfeit Drug Websites

In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication

Novo Nordisk Plant Faces FDA Scrutiny, Off-Label GLP-1 Use Grows, and AbbVie Expands Psychiatry Pipeline

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

Novo Nordisk’s Indiana Plant Flagged by FDA for Contamination and Safety Lapses

Image Credit: Adobe Stock Images/TadaImages.com Novo Nordisk has some facility issues to address. As first reported by STAT News,1 the

Johnson & Johnson Commits $2 Billion to North Carolina Manufacturing Expansion

Image Credit: Adobe Stock Images/MichaelVi.com Johnson & Johnson is all in on domestic manufacturing. The company announced plans to boost its

Combating Counterfeit Medicines Requires AI Integration and Industry Collaboration

In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication

Pharma Tariffs Take Shape, J&J Invests $2 Billion in US Manufacturing, and New EHR Rule Targets Prior Authorization

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

Pharma Regulatory Strategies Could Shift as Vaccine Support Declines

In a recent interview with Pharmaceutical Commerce, Ron Lanton, partner at Lanton Law, discussed the high-stakes implications of a new lawsuit

Building the Next-Generation Supply Chain Talent Pipeline (Episode 9)

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the

CVS Caremark Ordered to Pay $290 Million in False Claims Act Whistleblower Case

Image Credit: Adobe Stock Images/ImagingL.com Following an eight-day bench trial, a judge has issued a final judgement ruling that pharmacy

White House and EU Finalize Trade Deal With 15% Cap on Pharma Tariffs

Image Credit: Adobe Stock Images/Aquir.com As noted by Pharm Exec,1 the White House and European Union today revealed a framework

What Supply Chain Leaders Need to Know About COVID Vaccine Policy Uncertainty

In a recent interview with Pharmaceutical Commerce, Ron Lanton, partner at Lanton Law, discussed the high-stakes implications of a new

New Technologies Drive Down Pharma Manufacturing Costs in the United States

In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a

Agile Drug Manufacturing Advances, Merck–Skyhawk RNA Deal, and Telehealth Expands Pharmacists’ Role

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

AI-Powered Tools Transform Fight Against Counterfeit Drugs

In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication

Battelle and Aprecia Partner With HHS and DARPA to Advance Agile Drug Manufacturing

Image Credit: Adobe Stock Images/Parintron.com Via financial support from the US Department of Health and Human Services (HHS) Administration for

Counterfeiters Target Fragmented Pharma Supply Chains Through Digital Marketplaces

In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication

GLP-1 Access Partnership, Pfizer’s Sickle Cell Setback, and Patient Portal Trade-Offs

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

The Tariff Saga Continues

It’s been about six months since the trade wars pitting the US vs. various global nations and regions have commenced,

A Pharma Wholesaler Scorecard

Mike Hennessy Jr, chairman and CEO, MJH Life Sciences Every stakeholder’s role in the pharmaceutical supply chain is just as

US API Stockpile Plan, Mounjaro Price Hike in UK, and New Data on Vaccine Safety

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

Goodpath Partners With GiftHealth to Expand Access to GLP-1 Therapies Through LillyDirect

Image Credit: Adobe Stock Images/Thanayut.com Goodpath, a virtual clinic for chronic health conditions, has reached a pharmacy integration deal with GiftHealth,

Pharma Leaders Stress Tailored, Balanced Approach to Long-Term Manufacturing Strategy (Episode 8)

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the

Gross-to-Net Bubble Reshapes Drug Pricing Strategy

Welcome to the explainer. Today, we are talking about the wild and honestly, super complex world of drug pricing, and

Pharmaceutical Commerce: August 2025 Interactive Digital Edition

View the Pharmaceutical Commerce August 2025 issue in an interactive format.

Pharma Wholesalers: Looking for Growth

Future Focal Points for Distributors Deepen specialty and MSO integration. Continue expanding into management service organizations and specialty care networks

AI-Powered Counterfeit Drug Schemes Pose Growing Threat to Patient Safety

In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication

Redefining the Model for Modern Pharma Marketing

Daniel J. Gandor, EVERSANA Key Takeaways True omnichannel in pharma is a unified, customer-first marketing model—not just digital or multichannel

Potential 250% Pharma Tariffs Could Pressure Margins Without Directly Raising Patient Costs

In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a

Caveat Emptor in the Gray Market

Key Takeaways High-profile counterfeit medicine cases—from the 2019 Kentucky SURGICEL incident to counterfeit HIV drugs and Ozempic—expose vulnerabilities in the

Insurance Barriers Delaying Patient Care

Key Takeaways Patient access to treatment remains poor. For the second year in a row, patients with chronic conditions rated

A Rebate Double-Whammy: Exploring the Unintended Consequences

Key Takeaways GSK discontinued Flovent HFA and replaced it with a generic to avoid new Medicaid rebate rules that would

Novo Nordisk Ramps Up Legal Fight Against Compounded Semaglutide Knockoffs

Image Credit: Adobe Stock Images/Ibnu.com Novo Nordisk recently filed 14 new lawsuits intended to protect patients from unapproved compounded drugs

Pharma Pulse: Redefining the Pharmacy Aisle

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

Bayer Restructures, Lilly’s Oral GLP-1 Advances, and Court Ruling Shakes Up Obesity Drug Market

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,

FDA Launches PreCheck Program to Strengthen US Drug Manufacturing

Image Credit: Adobe Stock Images/PostmodernStudio.com At a time when more than 50% of pharmaceuticals distributed in the United States are

Maximizing Supply Chain Efficiency Without Overreacting to Tariffs (Episode 7)

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the

The Role of Digital Tools and Validation Expertise

In the highly regulated world of life sciences, compliance isn’t just a box to check; it is the foundation of

Balancing AI Ambition With Cost Pressures in Pharma

In a video interview with Pharma Commerce, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, he describes how the One Big

Tariffs Could Potentially Hit 250%

Image Credit: Adobe Stock Images/DavideBonaldo.com Last week, President Trump issued letters to 17 of the largest pharmaceutical companies, expressing dire

Ways Pharma Supply Chains Can Cut Scope 3 Emissions Now

In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of US supply chain, describes how today’s distribution networks

How Pharma Can Navigate Innovation and Cost Pressures in the GLP-1 Era

In a video interview with Pharma Commerce, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, he describes how the One Big

Lessons From Shortages and Global Disruptions

In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of US supply chain, describes how today’s distribution networks

Facing a Crossroads

In a video interview with Pharma Commerce, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, he describes how the One Big

Pharma Industry Shifts Toward Full Activation

In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of supply chain operations & distribution services, describes how

The Twin Forces Shaping Pharma Logistics Sustainability

In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of

What Clinical Ops Teams Must Know About Biomarkers in Trials; What is the Timeline for True AI Implementation for Digital Twins?

What Clinical Ops Teams Must Know About Biomarkers in Trials In an interview with Applied Clinical Trials, Michael Miller, COO

Balancing Compliance and Supply Chain Continuity

In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of supply chain operations & distribution services, describes how

FDA Delays Regeneron’s Odronextamab, Eylea HD Regulatory Decisions Over Catalent Site Issues

Credit: Ascannio | stock.adobe.com. The FDA has issued a second complete response letter (CRL) to Regeneron’s odronextamab based on issues

Trump’s MFN Drug Pricing Push Targets 17 Big Pharma Companies, Spurs Global Industry Response

As reported by Pharma Commerce sister publication, Pharmaceutical Executive,1 President Trump recently issued letters to 17 of the largest pharmaceutical

Leveraging Technology to Strengthen Pharma’s Fight Against Counterfeits (Episode 6)

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the

How Grocery-Based Pharmacies are Evolving into Community Health Hubs

Image Credit: Adobe Stock Images/AMuhSakaria.com As large pharmacy retailers scale back operations, community pharmacies—particularly those embedded within grocery stores—are stepping

Emission-Reduction Strategies That Save Money and Preserve Performance

In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of

Where Has AI Already Been Successfully Implemented; How Biomarkers Are Transforming Neurology and Oncology Trials

Where Has AI Already Been Successfully Implemented? In an interview with Pharmaceutical Executive, Gen Li, president and founder of Phesi,

Tackling ESG Data Gaps in Supplier and Third-Party Reporting

In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of

How Predictive Maintenance and Localized Distribution Are Shaping Pharma’s Future

In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of supply chain operations & distribution services, describes how

Weighing Cost Savings Against Safety and Regulatory Risks

In a video interview with Pharma Commerce, Hyung Heon Kim, CEO of MetaVia, describes how the current US payer ecosystem,

Practical Sustainability Metrics for Pharma

In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of

Unlocking Sustainability Across the Supply Chain

In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of

Scaling Obesity Drugs Responsibly

In a video interview with Pharma Commerce, Hyung Heon Kim, CEO of MetaVia, describes how the current US payer ecosystem,

Balancing DEI Reporting with Legal Risk; What the Emrelis Approval Means for Pharma and Biotech ADC Strategies

Balancing DEI Reporting with Legal Risk In an interview with Applied Clinical Trials, Kate Gallin Heffernan, a life sciences attorney

Leveraging Digital Twins and Analytics to Optimize Global Pharma Supply Chains

In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff

How Life Sciences Firms Are Evolving to Navigate Trade, Tariff, and Pricing Turbulence

Sixty percent of life sciences and healthcare leaders are anticipating that the current or forthcoming tariffs and pricing policies will

Supply Chain Blind Spots Threatening Pharma Integrity (Episode 5)

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the

Cold Chain Technologies, E&I Cooperative Services Strike Deal to Provide Schools with Expedited Access to Cold Chain Solutions

Image Credit: Adobe Stock Images/Sardar Key Takeaways Expanded Educational Access: Cold Chain Technologies (CCT) partners with E&I Cooperative Services to

How Pharma Executives Can Prepare for Tariff Uncertainty

In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff

Driving Adherence and Safety Through Digital Innovation

Patient safety and medication adherence are some of the major concerns in the pharmaceutical industry. With an increase in medication

Recapping the Sarepta Saga—And Implications for Industry

The controversy surrounding embattled gene therapy company Sarepta Therapeutics, including its drug, Elevidys, for Duchenne muscular dystrophy, continues to captivate

Building Inventory and Navigating FDA Hurdles in a Tariff-Driven Market

In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff

Can Dual Agonists Deliver Better Outcomes?

In a video interview with Pharma Commerce, Hyung Heon Kim, CEO of MetaVia, describes how the current US payer ecosystem,

The Ripple Effect of 200% Tariffs on US Drug Supply and Pricing

In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff

Coverage Gaps and Challenges Ahead for Obesity Drugs

In a video interview with Pharma Commerce, Hyung Heon Kim, CEO of MetaVia, describes how the current US payer ecosystem,

Balancing Awareness and Assurance

In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical

How Competition, Access, and Reimbursement Will Shape the Next Wave of Innovation

In a video interview with Pharma Commerce, Murray Aitken, executive director of the IQVIA Institute for Human Data Science, explains

Trump Says Pharma Industry Should Expect Tariffs by Aug. 1

President Trump noted that the pharma sector should prepare for levies by the beginning of next month, which could coincide

The Biosimilar Void

In a video interview with Pharma Commerce, Murray Aitken, executive director of the IQVIA Institute for Human Data Science, explains

How Parexel Supports Cross Functional Trials for Emerging GLP-1 Therapies; Eisai Explores Novel Dual Mechanism Therapy for Advanced Endometrial Carcinoma

How Parexel Supports Cross Functional Trials for Emerging GLP-1 Therapies In an interview with Applied Clinical Trials, Shipra Patel, global

Racial, Social, and Economic Factors Drive Resilience During COVID-19 Pandemic, Study Finds

Resilience, which is the concept of defying adversity and recovering from hardship, is connected to one’s health and well-being. Image

How DSCSA Is Transforming Supply Chain Data Exchange (Episode 4)

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the

The Hidden Challenge of Reporting Counterfeit Medicines

In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical

Why Medical Education Must Catch Up

In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical

How Pharma Must Evolve in a Competitive Therapeutic Landscape

In a video interview with Pharma Commerce, Murray Aitken, executive director of the IQVIA Institute for Human Data Science, explains

Knipper Health Taps Willis Chandler as New President and CEO

Chandler’s pharmaceutical experience spans years in the pharma services space, powered by strategic leadership roles. Image Credit: Knipper Health Following

From Data to Insight: Forecasting Global Medicine Use

In a video interview with Pharma Commerce, Murray Aitken, executive director of the IQVIA Institute for Human Data Science, explains

Gilead, Global Fund Partner to Expand Access to Lenacapavir

Gilead plans to supply enough doses to assist up to two million individuals over three years in nations supported by

Why Every Employee Needs to Be Part of the Journey

Few times in the evolution of a pharmaceutical company are as exciting as during the flurry of launch readiness activities

Removing Financial Barriers to Boost Trial Diversity; How Prescribing Power Has Shifted Beyond Physicians

Removing Financial Barriers to Boost Trial Diversity In an interview with Applied Clinical Trials, Heather Horville, solutions consultant, Greenphire, emphasized

Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access

Despite these medications being both available and affordable, racial, ethnic, and socioeconomic disparities came to light when it came to

A Look Under the Hood of Medicaid Support

In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and

How Pharma Can Detect Supply Chain Failures Before They Happen (Episode 3)

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the

Sustaining Regulatory Engagement Through Industry and Advocacy Collaboration

PC: In the absence of public participation at the federal level, how can industry leaders collaborate with advocacy groups to

Reducing Healthcare Prices

In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and

Pharma Industry Should Brace for up to 200% Tariffs

President Trump noted that import taxes on pharmaceuticals of up to 200% could come forthcoming. Image Credit: Adobe Stock Images/MohammadXte.com

Rising Costs, Shrinking Margins

In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and

Trump Imposes 25% Tariffs on Japan, South Korea, and a Dozen Other Nations

All of the levies come with a stipulation—if these nations increase their tariffs, the United States will raise them on

What Payers Really Want from High Cost Therapies in Rare Diseases

PC: How might this change affect payer negotiations and reimbursement decisions, particularly for innovative or high-cost therapies? Leuchter: When it

Aligning Real-World Evidence with Payer Perspectives

The trust gap between real-world evidence (RWE)/data and randomized controlled trials is growing. This episode examines when each evidence type

How Industry Stakeholders View Medicare Advantage Expansion for Patients with Kidney Disease

A qualitative study explored how representatives from MA plans, kidney care management companies, and dialysis organizations view the expansion and

Patient Engagement Is Critical to Developing Breakthrough Treatments

PC: What risks do you foresee for companies developing first-in-class therapies if patient perspectives are no longer formally incorporated into

Building Patient Centricity into Clinical Trial Software from Day One; Industry Voices on Current Pricing and Reimbursement Models

2025 DIA Annual Meeting: Building Patient Centricity into Clinical Trial Software from Day One In an interview with Applied Clinical

The Hidden Costs of Zero-Premium Plan Turnover

Image Credit: Adobe Stock Images/TadaImages.com As a result of the Patient Protection and Affordable Care Act (ACA), 24.2 million people

Preparing for Federal Regulations; Funding Cuts Threaten Diversity in Clinical Research

Preparing for Federal Regulations: Q&A with John Stanford In an interview with Pharmaceutical Executive, John Stanford, executive director at Incubate,

Novo Nordisk Expands Wegovy Access Through New WeightWatchers Partnership

Novo Nordisk is growing coverage of its Wegovy injection 2.4 mg in the form of a new deal with WeightWatchers

Oncology Care Index Spurs J&J to Address Fragmentation in Cancer Treatment; How Funding Cuts Are Undermining Patient Recruitment in Clinical Trials

Oncology Care Index Spurs J&J to Address Fragmentation in Cancer Treatment In an interview with Pharmaceutical Executive, Biljana Naumovic, US

The Impact of FDA’s Ban on Compounded GLP-1s; How Sites and Sponsors Are Adapting to Clinical Trial Budget Cuts

The Impact of FDA’s Ban on Compounded GLP-1s A Pharmaceutical Executive article explores how the FDA’s ban on compounded semaglutides—following

Hikma Commits $1 Billion to Boost US Drug Manufacturing and R&D Services by 2030

This investment exemplifies Hikma’s interest in raising the volume of meds it creates and produces across its various R&D and

Multi-Indication Drug Branding in Today’s Pharmaceutical Industry

Historically, new drugs were approved for a single therapeutic use. However, industry trends have shifted, with pharmaceutical companies increasingly identifying

The Evolution of the CGT Launch and Distribution Model

In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of

How Patient Advocacy Is Guiding Rare Disease Drug Development

PC: What role has public participation historically played in shaping healthcare policy, and why is it important for pharma and

Medicaid’s Role in the CGT Sector

Medicaid is especially critical for children with rare diseases, due to their need for intensive specialty care and higher risk

Delivering Value Beyond the Trial with Real-World Evidence

Real-world evidence (RWE) is no longer optional—it’s expected. This episode dives into how payers assess RWE alongside clinical trial data,

Leading by Example

In the fourth part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explains the

The Importance of Early Patient Feedback in Digital Endpoint Development; Developing FP&A Strategies in Today’s Environment

2025 DIA Annual Meeting: The Importance of Early Patient Feedback in Digital Endpoint Development In an interview with Applied Clinical

Overcoming Regulatory Barriers to Market Access

As international price referencing tightens and payer expectations rise, companies face a shrinking margin for error. The panel explores how

How CRO Partnerships Are Evolving to Meet Changing Industry Demands; Don’t Fall for the Call of Placebo-Controlled Vaccine Trials

How CRO Partnerships Are Evolving to Meet Changing Industry Demands In an interview with Applied Clinical Trials, Judith Ng-Cashin, MD,

How AI and Machine Learning Can Improve Patient Reported Outcomes in Clinical Trials; The Role of Patient Advocacy in Shaping AbbVie’s Cancer Therapies

2025 DIA Annual Meeting: How AI and Machine Learning Can Improve Patient Reported Outcomes in Clinical Trials In an interview

Developing a Manufacturing Contingency Plan (Episode 2)

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the

Discovering AI’s Role in Drug Safety Monitoring

Pharmaceutical Commerce: FDA staff cuts have created a critical gap in adverse drug event (ADE) monitoring. With ADEs being the

Does Risk-Based Payment Drive Better Care in Medicare Advantage?

Investigators aimed to examine the quality and efficiency under the FFS MA and at-risk MA models as a way to

Utilizing AI in Today’s Current Landscape

In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of

Xcellbio, Thermo Fisher Team up to Advance Cell Therapy Manufacturing

The purpose of the partnership is to help further develop the Treg and TIL cell therapies that are intended to

Supply Chain Planning in the Current CGT Climate

In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of

Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program

Preparing for CGT Launches

In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of

Current Perspective on Pricing and Reimbursement Models

This Peer Exchange® starts off with an introduction of the panel: Edward Ahn, CEO of MEDIPOST, Inc.; Rob Philo, Founder

Fixing the Pharma Pricing Puzzle

In a video interview with Pharma Commerce, LeAnn Boyd, PharmD, Liviniti’s founder and CEO, discusses the deeper, systemic issues behind

June 2025 Interactive Digital Edition

Pharmaceutical Commerce: June 2025 Interactive Digital Edition DSCSA Compliance: The Time is Now Conference Connect: Determining the Future of Specialty

Strategic Planning in the Rebate Economy; The Truth About AI Adoption Speed in Clinical Research

Strategic Planning in the Rebate Economy: What Pharma Must Do Now A recent Pharmaceutical Executive article outlines how, despite decades

Establishing Additional Transparency

In a video interview with Pharma Commerce, LeAnn Boyd, PharmD, Liviniti’s founder and CEO, discusses the deeper, systemic issues behind

Antares Vision Group Debuts AI-Powered Visual Inspection Platform

AI-GO blister inspection. Image Credit: Antares Vision Group Antares Vision Group, a provider of track-and-trace systems for several fields including

Understanding the Pharma Supply Chain (Episode 1)

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the

Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success; Innovation Requires Investment—and Sustained Investment Requires Sufficient Returns

Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success In an interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief

How Medicare Eligibility Affects Healthcare Use in Adults with Psychological Distress

Image Credit: Adobe Stock Images/DigitalMagicVisions.com One of several public health issues of utmost importance are mental health disorders, which are

TekniPlex Healthcare Unveils New Barrier Protection Systems Plant

TekniPlex Healthcare, a supplier of barrier films, unit-dose containers, and more, has opened its new 200,000-square-foot facility in Madison, WI, which

The Impact of Initial Coverage Choice

Image Credit: Adobe Stock Images/Rawpixel.com Data show that nearly two-thirds of Medicare beneficiaries feel that their coverage completely meets their

Changing the PAP Model

The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.

Bolstering Health Technology Assessment With the Help of AI

Key Takeaways AI enhances traditional HTA by improving accuracy and efficiency. Artificial intelligence addresses key limitations of traditional health technology

Raising the Alarm

Key Takeaways Lack of Awareness Among Healthcare Providers. Despite being the first line of defense, most HCPs receive little to

Policy Whiplash? 24 Hours in the Hub Still Matters More

Key Takeaways Speed is Critical. The first 24 hours after a prescription are crucial—nearly half of patients are lost immediately

What Is Smart Pharma Packaging?

In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, defines “smart pharma packaging” as the integration of technology

Financial Assistance Programs and Healthcare Plan Navigation

June 12, 2025 Amy Niles, chief mission officer, PAN Foundation, provides a deep dive into patient awareness of financial assistance

Embedded Product Intelligence’s Role in Maintaining Cold Chain Integrity

In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, defines “smart pharma packaging” as the integration of technology

Reviewing the Most-Favored Nation Model

Key Takeaways Reintroduction of the MFN model. The Trump Administration has revived the most-favored nation (MFN) drug pricing model as

Extreme Examples of Who Grew the Bubble

Key Takeaways Price hikes, not launch prices, drove the GTN bubble. The real driver of the gross-to-net (GTN) bubble was

Addressing the Threat of Prescription Abandonment

Sticker shock at the pharmacy counter has become an all-too-familiar experience for both patients and providers. The rising cost of

Navigating the Intersection of Accessibility and Measurement Integrity in eCOA; Do We Really Pay More for Prescription Drugs in the United States?

Navigating the Intersection of Accessibility and Measurement Integrity in eCOA An article in Applied Clinical Trials explores how clinical research’s

DHL Officially Obtains CRYOPDP

Image Credit: Adobe Stock Images/Tippapatt.com Key Takeaways DHL has acquired Cryoport’s specialty courier business, CRYOPDP, for approximately $200 million, strengthening

Using Data to Influence Drug Pricing Policy

In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role

The Financial Burden of Alzheimer’s Disease and Related Dementias

Image Credit: Adobe Stock Images/BeaunittaVanWyk.com Key Takeaways Alzheimer’s disease affects nearly 6.9 million older U.S. adults, making it the most

Transforming Care for COPD; Pharmacists Provide Harm Reduction Services to Patients With Substance Use Disorder

Transforming Care for COPD: Q&A with Barry Quart In an interview with Pharmaceutical Executive, Barry Quart, CEO, Connect Biopharma, discussed

The Connection Between Virtual Care and Language Barriers

Image Credit: Adobe Stock Images/Nattakorn.com Key Takeaways Language barriers reduce access to video-based virtual care: Adult patients facing language barriers

Exploring Perspectives of Fair Market Value in Clinical Trial Budgeting; New Technology Helps Prevent Opioid Overdose

Exploring Perspectives of Fair Market Value in Clinical Trial Budgeting An Applied Clinical Trials article explores the complex and often

Sanofi to Begin Globally Shipping Beyfortus Ahead of RSV Season

Image Credit: Adobe Stock Images/Artur.com Key Takeaways Sanofi is shipping Beyfortus early to ensure strong supply for the 2025–2026 RSV

Preparing for the Pharma C-Suite; America’s Vanishing Scientific Research Workforce is a Threat to Public Health

Preparing for the Pharma C-Suite In a Pharmaceutical Executive feature, Aileen Fernandes, Chief Business Officer at Arcellx, reflects on how

Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them; Wegovy Use Up 50% Among US Teens

Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them In a Pharmaceutical Executive feature,

Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization; Rethinking Clinical Trial Efficiency Amidst Cost Pressures on Pharma

Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization A Pharmaceutical Executive article explores how specialty pharmacy

GLP-1 Drugs May be Linked to Elevated Risk of Serious Eye Disease; Incyte’s Zynyz Wins FDA Approval as Single and Combo Therapy for Anal Cancer

GLP-1 Drugs may be Linked to Elevated Risk of Serious Eye Disease, Study Finds A new observational study finds that

Mapping the Hidden Costs

In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role

The Variation in Dual-Eligible Beneficiary Characteristics across Medicare Advantage Plan Types

Image Credit: Adobe Stock Images/Wladimir1804.com Key Takeaways MA enrollment among full-benefit dual-eligible beneficiaries is rising, reaching nearly 50% by 2022.